$500M 0% Convertible Notes Priced at 35% Premium; Proceeds to Retire 2027 Notes
GH has more than doubled off its 52-week low of $74.55.
Summary
Guardant priced $500 million of 0% convertible senior notes due 2032 at a 35% conversion premium, implying an initial conversion price of about $208.95 versus the $154.78 last sale on November 11. The deal follows yesterday's launch announcement and adds the terms that matter: no coupon, a capped call with a $309.56 cap to blunt dilution, and an option for up to $50 million more. Net proceeds of roughly $489.3 million (about $538.3 million with the full option) go mainly to repurchasing about $395.2 million of the 2027 notes, with $51.7 million funding the capped call cost. The structure is a refinancing rather than fresh growth capital, and the zero coupon plus 35% premium points to solid demand. Watch the November 16 settlement and any hedging flows from the option counterparties, which the company flags could be substantial relative to average daily volume.
At the time of this announcement, GH was trading at $155.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.9B. The 52-week trading range was $74.55 to $191.05. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.